EUVIMEDEUVIMED entdecken
Crossref

Extracellular vesicles: Frontier research driving cancer therapy toward precision and efficiency

Shuang Ma, Guangyu Zhao, Ziyi Li, Wanying Xu, Jiaxuan Wu, Lingyu Kong, Xiaolin Wu, Tao Yan

Chinese Medical Journal BioMed · 11.11.2026

DOI: 10.65457/cmjbm-2026-0010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chinese Medical Journal BioMed, online erschienen am 11.11.2026. Verfasst von Shuang Ma und 7 weiteren Autor:innen. Die Arbeit nennt 134 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) have emerged as critical mediators of intercellular communication and hold transformative potential in precision medicine, owing to their biocompatibility, low immunogenicity, and ability to cross biological barriers. This review synthesized current methodologies for therapeutic cargo loading and advanced engineering strategies for EVs, emphasizing their translational applications in cancer therapy, especially in glioblastoma (GBM). We categorized drug-loading approaches into pre-loading (e.g., metabolic or genetic engineering) or post-loading methods (e.g., electroporation or sonication), highlighting their respective advantages and limitations. Engineering strategies, including biological, immunological, physical, and chemical modifications, are evaluated for their roles in enhancing targeting efficiency, therapeutic payload stability, and immune modulation. Engineered and biomimetic EVs have been used to deliver chemotherapeutic agents, immunotherapeutics, and gene-editing tools, with a focus on their capacity for combination therapies and overcoming physiological barriers such as the blood–brain barrier (BBB). Finally, we assessed the clinical potential of EVs for the diagnosis, prognosis, and treatment of various cancers (including GBM and other solid/hematological malignancies) via liquid biopsy and multimodal delivery vehicles. Collectively, this review underscored the promise of EVs as next-generation platforms for targeted drug delivery and precision oncology, while identifying key challenges—including loading efficiency, standardization, and immunogenicity—that must be addressed to advance clinical translation.

Zitieren

APA

Ma, S., Zhao, G., Li, Z., Xu, W., Wu, J., Kong, L., Wu, X., & Yan, T. (2026). Extracellular vesicles: Frontier research driving cancer therapy toward precision and efficiency. Chinese Medical Journal BioMed. https://doi.org/10.65457/cmjbm-2026-0010

Vancouver

Ma S, Zhao G, Li Z, Xu W, Wu J, Kong L, et al. Extracellular vesicles: Frontier research driving cancer therapy toward precision and efficiency. Chinese Medical Journal BioMed. 2026. doi:10.65457/cmjbm-2026-0010

BibTeX
@article{Ma2026,
  author = {Ma, Shuang and Zhao, Guangyu and Li, Ziyi and Xu, Wanying and Wu, Jiaxuan and Kong, Lingyu and Wu, Xiaolin and Yan, Tao},
  title = {Extracellular vesicles: Frontier research driving cancer therapy toward precision and efficiency},
  journal = {Chinese Medical Journal BioMed},
  year = {2026},
  doi = {10.65457/cmjbm-2026-0010}
}
Kostenlos starten →